Biotechs stall as risk appetite fades

By Brian Robins
Updated December 31 2014 - 1:08am, first published December 29 2014 - 12:30am

What a difference a year makes. The downturn in mining stocks from 2013 saw hot money flow into the biotech sector. But after some spectacular research failures, sentiment soured, leaving the sector firmly in the shadows for much of 2014 so that even the surge in biotech stocks globally bypassed the local players.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options
More from Business

Get the latest Batemans Bay news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.